AMPH
Price
$29.62
Change
-$0.71 (-2.34%)
Updated
Aug 20 closing price
Capitalization
1.41B
81 days until earnings call
BHC
Price
$7.58
Change
-$0.21 (-2.70%)
Updated
Aug 20 closing price
Capitalization
2.89B
70 days until earnings call
Interact to see
Advertisement

AMPH vs BHC

Header iconAMPH vs BHC Comparison
Open Charts AMPH vs BHCBanner chart's image
Amphastar Pharmaceuticals
Price$29.62
Change-$0.71 (-2.34%)
Volume$434.16K
Capitalization1.41B
Bausch Health Companies
Price$7.58
Change-$0.21 (-2.70%)
Volume$2.24M
Capitalization2.89B
AMPH vs BHC Comparison Chart in %
Loading...
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMPH vs. BHC commentary
Aug 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMPH is a Buy and BHC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 21, 2025
Stock price -- (AMPH: $30.33 vs. BHC: $7.79)
Brand notoriety: AMPH: Not notable vs. BHC: Notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AMPH: 98% vs. BHC: 97%
Market capitalization -- AMPH: $1.41B vs. BHC: $2.89B
AMPH [@Pharmaceuticals: Generic] is valued at $1.41B. BHC’s [@Pharmaceuticals: Generic] market capitalization is $2.89B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.99B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMPH’s FA Score shows that 0 FA rating(s) are green whileBHC’s FA Score has 1 green FA rating(s).

  • AMPH’s FA Score: 0 green, 5 red.
  • BHC’s FA Score: 1 green, 4 red.
According to our system of comparison, BHC is a better buy in the long-term than AMPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMPH’s TA Score shows that 5 TA indicator(s) are bullish while BHC’s TA Score has 5 bullish TA indicator(s).

  • AMPH’s TA Score: 5 bullish, 5 bearish.
  • BHC’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both AMPH and BHC are a good buy in the short-term.

Price Growth

AMPH (@Pharmaceuticals: Generic) experienced а -0.07% price change this week, while BHC (@Pharmaceuticals: Generic) price change was +11.29% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.99%. For the same industry, the average monthly price growth was +9.96%, and the average quarterly price growth was +71.77%.

Reported Earning Dates

AMPH is expected to report earnings on Nov 10, 2025.

BHC is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.99% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BHC($2.89B) has a higher market cap than AMPH($1.41B). BHC has higher P/E ratio than AMPH: BHC (29.96) vs AMPH (11.36). BHC YTD gains are higher at: -3.350 vs. AMPH (-18.314). BHC has higher annual earnings (EBITDA): 3B vs. AMPH (248M). BHC has more cash in the bank: 1.73B vs. AMPH (232M). AMPH has less debt than BHC: AMPH (655M) vs BHC (21.7B). BHC has higher revenues than AMPH: BHC (9.86B) vs AMPH (723M).
AMPHBHCAMPH / BHC
Capitalization1.41B2.89B49%
EBITDA248M3B8%
Gain YTD-18.314-3.350547%
P/E Ratio11.3629.9638%
Revenue723M9.86B7%
Total Cash232M1.73B13%
Total Debt655M21.7B3%
FUNDAMENTALS RATINGS
AMPH vs BHC: Fundamental Ratings
AMPH
BHC
OUTLOOK RATING
1..100
2026
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
35
Fair valued
PROFIT vs RISK RATING
1..100
81100
SMR RATING
1..100
48100
PRICE GROWTH RATING
1..100
4038
P/E GROWTH RATING
1..100
8022
SEASONALITY SCORE
1..100
90n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BHC's Valuation (35) in the Pharmaceuticals Other industry is in the same range as AMPH (66). This means that BHC’s stock grew similarly to AMPH’s over the last 12 months.

AMPH's Profit vs Risk Rating (81) in the Pharmaceuticals Other industry is in the same range as BHC (100). This means that AMPH’s stock grew similarly to BHC’s over the last 12 months.

AMPH's SMR Rating (48) in the Pharmaceuticals Other industry is somewhat better than the same rating for BHC (100). This means that AMPH’s stock grew somewhat faster than BHC’s over the last 12 months.

BHC's Price Growth Rating (38) in the Pharmaceuticals Other industry is in the same range as AMPH (40). This means that BHC’s stock grew similarly to AMPH’s over the last 12 months.

BHC's P/E Growth Rating (22) in the Pharmaceuticals Other industry is somewhat better than the same rating for AMPH (80). This means that BHC’s stock grew somewhat faster than AMPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMPHBHC
RSI
ODDS (%)
Bearish Trend 1 day ago
64%
Bearish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 1 day ago
75%
Momentum
ODDS (%)
Bullish Trend 1 day ago
68%
Bullish Trend 1 day ago
66%
MACD
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
64%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
70%
Bullish Trend 1 day ago
72%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
71%
Advances
ODDS (%)
Bullish Trend 8 days ago
72%
Bullish Trend 6 days ago
75%
Declines
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 1 day ago
77%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
64%
Bearish Trend 1 day ago
73%
Aroon
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AUXIX33.020.09
+0.27%
Auxier Focus Institutional
GSBIX27.180.03
+0.11%
Goldman Sachs Income Builder Instl
JDVPX24.420.01
+0.04%
JHancock Disciplined Value R2
MBBIX12.73N/A
N/A
MassMutual Balanced I
ABEMX15.89-0.14
-0.87%
abrdn Emerging Markets Instl

AMPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMPH has been loosely correlated with COLL. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if AMPH jumps, then COLL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMPH
1D Price
Change %
AMPH100%
+1.92%
COLL - AMPH
39%
Loosely correlated
-1.47%
AMRX - AMPH
36%
Loosely correlated
+0.76%
ZTS - AMPH
33%
Loosely correlated
+2.20%
PAHC - AMPH
33%
Poorly correlated
+1.92%
VTRS - AMPH
32%
Poorly correlated
+0.47%
More